Show simple item record

dc.contributor.authorBorst, Gerben Ren
dc.contributor.authorPost, R.en
dc.date.accessioned2023-10-25T08:48:26Z
dc.date.available2023-10-25T08:48:26Z
dc.date.issued2023en
dc.identifier.citationBorst GR, Post R. Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis. Journal of neuro-oncology. 2023 Oct 9. PubMed PMID: 37812289. Epub 2023/10/09. eng.en
dc.identifier.pmid37812289en
dc.identifier.doi10.1007/s11060-023-04457-6en
dc.identifier.urihttp://hdl.handle.net/10541/626613
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1007/s11060-023-04457-6en
dc.titleLetter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysisen
dc.typeOtheren
dc.contributor.departmentDivision of Cancer Sciences, School of Medical Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health & Manchester Cancer Research Centre, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UKen
dc.identifier.journalJournal of Neuro-oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record